These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of dl-3-n-butylphthalide in a transgenic mouse model of amyotrophic lateral sclerosis. Feng XH; Yuan W; Peng Y; Liu MS; Cui LY Chin Med J (Engl); 2012 May; 125(10):1760-6. PubMed ID: 22800896 [TBL] [Abstract][Full Text] [Related]
9. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Zhang J; Ito H; Wate R; Ohnishi S; Nakano S; Kusaka H Acta Neuropathol; 2006 Dec; 112(6):673-80. PubMed ID: 16957927 [TBL] [Abstract][Full Text] [Related]
10. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium. Ferrucci M; Spalloni A; Bartalucci A; Cantafora E; Fulceri F; Nutini M; Longone P; Paparelli A; Fornai F Neurobiol Dis; 2010 Feb; 37(2):370-83. PubMed ID: 19874893 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Almer G; Guégan C; Teismann P; Naini A; Rosoklija G; Hays AP; Chen C; Przedborski S Ann Neurol; 2001 Feb; 49(2):176-85. PubMed ID: 11220737 [TBL] [Abstract][Full Text] [Related]
13. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase. Gowing G; Lalancette-Hébert M; Audet JN; Dequen F; Julien JP Exp Neurol; 2009 Dec; 220(2):267-75. PubMed ID: 19733170 [TBL] [Abstract][Full Text] [Related]
14. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation. Liu J; Allender E; Wang J; Simpson EH; Loeb JA; Song F Neurobiol Dis; 2018 Mar; 111():118-126. PubMed ID: 29278738 [TBL] [Abstract][Full Text] [Related]
15. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053 [TBL] [Abstract][Full Text] [Related]
16. Nortriptyline delays disease onset in models of chronic neurodegeneration. Wang H; Guan Y; Wang X; Smith K; Cormier K; Zhu S; Stavrovskaya IG; Huo C; Ferrante RJ; Kristal BS; Friedlander RM Eur J Neurosci; 2007 Aug; 26(3):633-41. PubMed ID: 17686041 [TBL] [Abstract][Full Text] [Related]
17. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. Zheng C; Sköld MK; Li J; Nennesmo I; Fadeel B; Henter JI Biochem Biophys Res Commun; 2007 Nov; 363(4):989-93. PubMed ID: 17923114 [TBL] [Abstract][Full Text] [Related]
18. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685 [TBL] [Abstract][Full Text] [Related]
19. Serotonergic mechanisms in amyotrophic lateral sclerosis. Sandyk R Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Drachman DB; Frank K; Dykes-Hoberg M; Teismann P; Almer G; Przedborski S; Rothstein JD Ann Neurol; 2002 Dec; 52(6):771-8. PubMed ID: 12447931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]